The Goldfarb Foundation > CME Meetings > 2022 Clinical Conference

Call for Abstracts & Poster Competition

The Goldfarb Foundation's 6th Annual Call for Abstracts & Poster Competition accepts abstract submissions March 15 through June 15, 2022. See the timeline below and the Competition Guidelines for more details.

Competition Timeline

Abstract submission timeframe: March 15 – June 15, 2022
Notification of acceptance in an email to the corresponding author: No later than August 5, 2022
PDF Submission Deadline: October 7, 2022
Poster setup: Thursday, November 3, 2022 4:00 pm – 8:00 pm
Posters on display: Friday, November 4, 2022 9:00 am – Saturday, November 5, 2022 4:00 pm
Poster Q&A: Saturday, November 5, 2022 10:00 am – 10:30 am
Poster Winners announced: Before 3:30 pm lecture on Saturday, November 5, 2022
Poster removal: Saturday, November 5, 2022 4:00 pm – 6:00 pm

Prizes

Three prizes* will be awarded in each division (Case & Scientific) to the winners:
$100, First Place
$75, Second Place
$50, Third Place

*Prizes subject to adjustment if a lack of posters are presented for judging.

Planning for 2022 Poster Competition

The 2022 Clinical Conference is being planned as a face-to-face meeting. Should the meeting change to a virtual format, the Poster Competition will adapt to a virtual environment as it did in 2020 and 2021.

Judging for the poster competition will occur in advance of the event based upon the submitted PDF files, regardless of the event format.

Poster Contest Research

Important Links

Competition Guidelines

Sample Abstract Submission Form

Judging Guidelines

Sample Abstract (Scientific)

Sample Poster (Scientific)

Sample Abstract (Case)

Sample Poster (Case)

Electronic Abstract Submission Form - Note that one you begin to complete the online form, you cannot save and return to it later. If you wish to submit it, you must do so in one sitting. Once you complete the Abstract Submission Form, you must complete the Author Disclosure Form for each author that has financial disclosures related to the research.